Evaluation of the level of HBV antibody titer after HBV vaccination among children in Tehran, Iran

Hepatitis Monthly

Volumn 9, Issue 2, 2009, Pages 150-153

  Hosseini, Seyed Mohammad Javad ^a   Ranjbar, Reza ^a   Abolghasemi, Hassan ^b   Turkaman, Mohammad ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b University of Medical Sciences   (Iran)

Author keywords

Children; HBV Antibody; Iran; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; VACCINATION;

EID: 70349278939     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kubba AK, Taylor P, Graneek B, Strobel S. Non-responders to hepatitis B vaccination: a review. Commun Dis Public Health. 2003; 6(2):106-12.
2. Rehermann B. Immune responses in hepatitis B virus infection. Semin Liver Dis. 2003;23(1):21-38.
3. Malekzadeh R, Khatibian M, Rezvani M. Viral hepatitis in the world and Iran. J Iran Med Council. 1997;15:183-200.
4. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg. 1993;96(5):277-87.
5. Organization WH. Geographic pattern of hepatitis B prevalence. 1997.
6. Zali MR, Mohammad K, Farhadi A, Masjedi MR, Zargar A, Nowroozi A. Epidemiology of hepatitis B in the Islamic Republic of Iran. 1996. p. 290-8.
7. McLean AA, Hilleman MR, McAleer WJ, Buynak EB. Summary of worldwide clinical experience with H-B-Vax (B, MSD). J Infect. 1983;7 Suppl 1:95-104.
8. American Academy of Pediatrics Committee on Infectious Diseases: Universal hepatitis B immunization. Pediatrics. 1992;89(4 Pt 2):795-800.
9. Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med. 1986;314(21):1393.
10. An international group, immunization against Hepatitis B. Lancet 1988;16:875-6.
11. Brook MG. Sexual transmission and prevention of the hepatitis viruses A-E and G. Sex Transm Infect. 1998;74(6):395-8.
12. Hom XB, Jonas MM. Sources of Viral Hepatitis in Children. WB SAUNDERS; 2000. p. 47-64.
13. Ahn YO. Strategy for vaccination against hepatitis B in areas with high endemicity: focus on Korea. Gut. 1996;38 Suppl 2:S63-6.
14. Hollinger FB. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med. 1989;87(3A):36S-40S.
15. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. Jama. 1985;254(22):3187-9.
16. Shaw FE, Jr., Guess HA, Roets JM, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine. 1989;7(5):425-30.
17. Hassan S, Ziba F. Antibody titer in Iranian children 6 years after hepatitis B vaccine administration. Vaccine. 2007; 25(17):3511-4.
18. Lozano MA, Caycho OJ, Antunez de Mayolo A, Vera D, Posadas RD. [Immunogenicity and efficacy of a new recombinant DNA vaccine for hepatitis B virus in Peru]. Rev Gastroenterol Peru. 2003; 23(4):259-64.
19. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005; 11(1-2):62-7.
20. Hussain Z, Ali SS, Husain SA, Raish M, Sharma DR, Kar P. Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India. World J Gastroenterol. 2005; 11(45):7165-8.
21. Sallam TA, Alghshm HM, Ablohom AA, et al. Immune response to Hepatitis B vaccine among children in Yemen. Saudi Med J. 2005; 26(2):281-4.